| Vifor (International) Inc. - Flucelvax, Injektionssuspension in einer Fertigspritze | | 70144 | | 01 | | Flucelvax | | Injektionssuspension in einer Fertigspritze | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 29.04.2026 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus Stamm A/Wisconsin/67/2022 (H1N1)-like: derived from A/Georgia/12/2022 CVR-167) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Massachusetts/18/2022 (H3N2)-like: derived from A/Sydney/1304/2022) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant from B/Singapore/WUH4618/2021 (Victoria lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.74 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum. | | Packungsbestandteile | | Injektionssuspension in einer Fertigspritze | | | | | | Active Agent | Dose |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/wisconsin/67/2022 (H1N1)-Like: Derived from A/georgia/12/2022 Cvr-167) | 15µg / 0.5ml | | Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/massachusetts/18/2022 (H3N2)-Like: Derived from A/sydney/1304/2022) | 15µg / 0.5ml | | Haemagglutininum Influenzae b (Virus Stamm B/austria/1359417/2021-Like: Reassortant from B/singapore/wuh4618/2021 (Victoria Lineage)) | 15µg / 0.5ml |
| | | | Inactive agents |
|---|
| Kalii Chloridum | | Potassium Dihydrogenophosphate | | Magnesium Chloride Hexahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | B | | No | | 002 | 10 | | | B | | No | | 003 | | | | B | | No | | 004 | 10 | | | B | | No |
|
|
